tiprankstipranks
Danaher Corp. (IT:1DHR)
:1DHR
Italy Market
1DHR
Danaher
RESEARCH TOOLSreports

Danaher (1DHR) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

1DHR Analyst Ratings

Strong Buy
20Ratings
Strong Buy
17 Buy
3 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Danaher
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1DHR Stock 12 Month Forecast

Average Price Target

€190.90
▲(12.96% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is €190.90 with a high forecast of €208.46 and a low forecast of €169.37. The average price target represents a 12.96% change from the last price of €169.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"151":"€151","180":"€180","209":"€209","165.5":"€165.5","194.5":"€194.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":208.4614512,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€208.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":190.8966437377778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€190.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":169.3749291,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€169.37</span>\n  </div></div>","useHTML":true}}],"tickPositions":[151,165.5,180,194.5,209],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.55,171.62011163076923,174.69022326153848,177.7603348923077,180.83044652307694,183.90055815384616,186.97066978461538,190.04078141538463,193.11089304615385,196.18100467692307,199.2511163076923,202.32122793846153,205.39133956923078,{"y":208.4614512,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.55,170.26897259521368,171.98794519042735,173.70691778564102,175.42589038085472,177.1448629760684,178.86383557128207,180.58280816649574,182.3017807617094,184.02075335692308,185.73972595213678,187.45869854735045,189.17767114256412,{"y":190.8966437377778,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.55,168.6134560846154,168.67691216923077,168.74036825384616,168.80382433846154,168.86728042307692,168.9307365076923,168.9941925923077,169.0576486769231,169.12110476153848,169.18456084615386,169.24801693076924,169.31147301538462,{"y":169.3749291,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":166.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.801,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.46,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.02,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":193.597,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.826,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.988,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.69,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.825,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.22,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.55,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€208.46Average Price Target€190.90Lowest Price Target€169.37
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on IT:1DHR
Luke Sergott
Barclays
Barclays
€199.78
Buy
18.21%
Upside
Reiterated
08/04/26
Danaher (DHR) Gets a Buy from Barclays
Bank of America Securities Analyst forecast on IT:1DHR
Michael Ryskin
Bank of America Securities
Bank of America Securities
€199.78
Buy
18.21%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)
Morgan Stanley Analyst forecast on IT:1DHR
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€191.09
Buy
13.07%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)
Goldman Sachs Analyst forecast on IT:1DHR
Evie Koslosky
Goldman Sachs
Goldman Sachs
€182.4
Buy
7.93%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Danaher (NYSE: DHR) and Henry Schein (NASDAQ: HSIC)
Piper Sandler Analyst forecast on IT:1DHR
David Westenberg
Piper Sandler
Piper Sandler
€173.72
Hold
2.79%
Upside
Reiterated
07/27/26
Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)
Jefferies Analyst forecast on IT:1DHR
Tycho Peterson
Jefferies
Jefferies
€182.4
Buy
7.93%
Upside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Danaher (NYSE: DHR)
Argus Research Analyst forecast on IT:1DHR
David Toung
Argus Research
Argus Research
€199.78
Buy
18.21%
Upside
Assigned
07/23/26
Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus
J.P. Morgan Analyst forecast on IT:1DHR
Casey Woodring
J.P. Morgan
J.P. Morgan
€212.8→€191.09
Buy
13.07%
Upside
Reiterated
07/23/26
J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
Wells Fargo Analyst forecast on IT:1DHR
Brandon Couillard
Wells Fargo
Wells Fargo
€184.14→€169.37
Hold
0.22%
Upside
Reiterated
07/22/26
Wells Fargo Remains a Hold on Danaher (DHR)
TD Cowen Analyst forecast on IT:1DHR
Daniel Brennan
TD Cowen
TD Cowen
€208.46→€204.99
Buy
21.29%
Upside
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)
William Blair Analyst forecast on IT:1DHR
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
07/22/26
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)
Stifel Nicolaus Analyst forecast on IT:1DHR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€225.83→€191.09
Buy
13.07%
Upside
Reiterated
07/22/26
Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel
Citi Analyst forecast on IT:1DHR
Patrick B Donnelly
Citi
Citi
€199.78
Buy
18.21%
Upside
Reiterated
07/22/26
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
Deutsche Bank Analyst forecast on IT:1DHR
Justin Bowers
Deutsche Bank
Deutsche Bank
€217.15→€208.46
Buy
23.35%
Upside
Assigned
07/22/26
Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank
Guggenheim Analyst forecast on IT:1DHR
Subbu Nambi
Guggenheim
Guggenheim
€204.12→€173.72
Buy
2.79%
Upside
Reiterated
07/21/26
Danaher price target lowered to $200 from $235 at GuggenheimDanaher price target lowered to $200 from $235 at Guggenheim
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on IT:1DHR
Luke Sergott
Barclays
Barclays
€199.78
Buy
18.21%
Upside
Reiterated
08/04/26
Danaher (DHR) Gets a Buy from Barclays
Bank of America Securities Analyst forecast on IT:1DHR
Michael Ryskin
Bank of America Securities
Bank of America Securities
€199.78
Buy
18.21%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)
Morgan Stanley Analyst forecast on IT:1DHR
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€191.09
Buy
13.07%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)
Goldman Sachs Analyst forecast on IT:1DHR
Evie Koslosky
Goldman Sachs
Goldman Sachs
€182.4
Buy
7.93%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Danaher (NYSE: DHR) and Henry Schein (NASDAQ: HSIC)
Piper Sandler Analyst forecast on IT:1DHR
David Westenberg
Piper Sandler
Piper Sandler
€173.72
Hold
2.79%
Upside
Reiterated
07/27/26
Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)
Jefferies Analyst forecast on IT:1DHR
Tycho Peterson
Jefferies
Jefferies
€182.4
Buy
7.93%
Upside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Danaher (NYSE: DHR)
Argus Research Analyst forecast on IT:1DHR
David Toung
Argus Research
Argus Research
€199.78
Buy
18.21%
Upside
Assigned
07/23/26
Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus
J.P. Morgan Analyst forecast on IT:1DHR
Casey Woodring
J.P. Morgan
J.P. Morgan
€212.8→€191.09
Buy
13.07%
Upside
Reiterated
07/23/26
J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
Wells Fargo Analyst forecast on IT:1DHR
Brandon Couillard
Wells Fargo
Wells Fargo
€184.14→€169.37
Hold
0.22%
Upside
Reiterated
07/22/26
Wells Fargo Remains a Hold on Danaher (DHR)
TD Cowen Analyst forecast on IT:1DHR
Daniel Brennan
TD Cowen
TD Cowen
€208.46→€204.99
Buy
21.29%
Upside
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)
William Blair Analyst forecast on IT:1DHR
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
07/22/26
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)
Stifel Nicolaus Analyst forecast on IT:1DHR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
€225.83→€191.09
Buy
13.07%
Upside
Reiterated
07/22/26
Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel
Citi Analyst forecast on IT:1DHR
Patrick B Donnelly
Citi
Citi
€199.78
Buy
18.21%
Upside
Reiterated
07/22/26
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
Deutsche Bank Analyst forecast on IT:1DHR
Justin Bowers
Deutsche Bank
Deutsche Bank
€217.15→€208.46
Buy
23.35%
Upside
Assigned
07/22/26
Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank
Guggenheim Analyst forecast on IT:1DHR
Subbu Nambi
Guggenheim
Guggenheim
€204.12→€173.72
Buy
2.79%
Upside
Reiterated
07/21/26
Danaher price target lowered to $200 from $235 at GuggenheimDanaher price target lowered to $200 from $235 at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
TNYATenaya Therapeutics
JBIOJade Biosciences
GHRSGH Research
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Danaher

3 Months
Dan LeonardRBC Capital
Success Rate
16/21 ratings generated profit
76%
Average Return
+9.25%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +9.25% per trade.
1 Year
Dan LeonardRBC Capital
Success Rate
15/21 ratings generated profit
71%
Average Return
+22.53%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +22.53% per trade.
2 Years
Dan LeonardRBC Capital
Success Rate
16/21 ratings generated profit
76%
Average Return
+38.92%
Copying Dan Leonard's trades and holding each position for 2 Years would result in 76.19% of your transactions generating a profit, with an average return of +38.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1DHR Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
1
2
2
1
Buy
25
23
26
25
26
Hold
2
2
5
5
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
26
33
32
32
In the current month, 1DHR has received 27 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 1DHR average Analyst price target in the past 3 months is 190.90.
Each month's total comprises the sum of three months' worth of ratings.

1DHR Financial Forecast

1DHR Earnings Forecast

Next quarter’s earnings estimate for 1DHR is €1.67 with a range of €1.64 to €1.73. The previous quarter’s EPS was €1.69. 1DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1DHR is €1.67 with a range of €1.64 to €1.73. The previous quarter’s EPS was €1.69. 1DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.

1DHR Sales Forecast

Next quarter’s sales forecast for 1DHR is €5.68B with a range of €5.42B to €5.80B. The previous quarter’s sales results were €5.44B. 1DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.71% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.
Next quarter’s sales forecast for 1DHR is €5.68B with a range of €5.42B to €5.80B. The previous quarter’s sales results were €5.44B. 1DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.71% of the time in the same period. In the last calendar year 1DHR has Performed in-line its overall industry.

1DHR Stock Forecast FAQ

What is IT:1DHR’s average 12-month price target, according to analysts?
Based on analyst ratings, Danaher Corp.’s 12-month average price target is 190.90.
    What is IT:1DHR’s upside potential, based on the analysts’ average price target?
    Danaher Corp. has 12.96% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Danaher Corp. a Buy, Sell or Hold?
          Danaher Corp. has a consensus rating of Strong Buy, which is based on 17 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Danaher Corp.’s share price target?
            The average share price target for Danaher Corp. is 190.90. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €208.46 ,and the lowest forecast is €169.37. The average share price target represents 12.96% Increase from the current price of €169.
              What do analysts say about Danaher Corp.?
              Danaher Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of Danaher Corp.?
                To buy shares of IT:1DHR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.